News | January 31, 2022
Granules Pharmaceuticals concludes USFDA audit with three minor observations
The audit is a PAI for two of its product applications filed from this facility
The audit is a PAI for two of its product applications filed from this facility
The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna's mRNA technology
UCB plans to submit regulatory applications in Q3 2022
The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
It is the first monoclonal antibody drug for use in any animal species
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000
The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)
The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
Subscribe To Our Newsletter & Stay Updated
